12:00 AM
 | 
Apr 16, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Spaltudaq Corp.

Seattle, Wash.

Technology: Human B cell-based monoclonal antibody discovery platform

Disease focus: Cancer,...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >